ÎÞÓǶÌÊÓƵ expands senior team with four female hires in further preparation for cell therapies.
23.06.2022ÎÞÓǶÌÊÓƵ expands senior team with four female hires in further preparation for cell therapies.
ÎÞÓǶÌÊÓƵ expands senior team with four female hires in further preparation for cell therapies.
23.06.2022ÎÞÓǶÌÊÓƵ expands senior team with four female hires in further preparation for cell therapies.
The award was presented at evening ceremony in central London.
17.06.2022The posters demonstrate the capability of opti-ox technology to create any human cell.
15.06.2022ÎÞÓǶÌÊÓƵ and Charles River Laboratories discuss the potential of precision reprogrammed human cells.
26.05.2022The piece talks about how ÎÞÓǶÌÊÓƵ has "cracked the code" to grow human cells for a new era of regenerative medicine.
22.05.2022ÎÞÓǶÌÊÓƵ wins biotech of the year for the second time and CEO of the year for Mark Kotter.
11.05.2022The new Huntington’s disease human cell model is built with opti-ox reprogrammed glutamatergic neurons.
08.05.2022We were delighted to welcome CEO National Resilience Inc. Rahul Singhvi who visited our labs and office space.
04.05.2022Mark Kotter talks about the benefits of human cells for researchers, and how they can shape the future of drug development.
21.04.2022